Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Entinostat

From Wikipedia, the free encyclopedia
Entinostat
Names
Preferred IUPAC name
(Pyridin-3-yl)methyl ({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate
Other names
SNDX-275; MS-275
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard100.158.999Edit this at Wikidata
KEGG
UNII
  • InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26) ☒N
    Key: INVTYAOGFAGBOE-UHFFFAOYSA-N ☒N
  • InChI=1/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)
    Key: INVTYAOGFAGBOE-UHFFFAOYAU
  • C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3
Properties
C21H20N4O3
Molar mass376.4085 g/mol
Pharmacology
L01XH05 (WHO)
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Chemical compound

Entinostat, also known asSNDX-275 andMS-275, is abenzamidehistone deacetylase inhibitor undergoing clinical trials for treatment of various cancers.[1][2][3][4]

Entinostat inhibits class IHDAC1 andHDAC3 withIC50 of 0.51 μM and 1.7 μM, respectively.[5]

Syndax pharmaceuticals currently holds the rights to entinostat and recently received $26.6 million in funds to advance treatments of resistant cancers using epigenetic tools.[6]

It has also been investigated as a potentialmale contraceptive drug.[7]

References

[edit]
  1. ^Juergens RA, Vendetti F, Coleman B, Sebree RS, Rudek MA, Belinsky SA, et al. (May 2008). "Phase I trial of 5-azacitidine (5AC) and SNDX-275 in advanced lung cancer (NSCLC)".Journal of Clinical Oncology.26 (15_suppl): 19036-.doi:10.1200/jco.2008.26.15_suppl.19036.
  2. ^Kiany S, Harrison D, Gordon N (2020). "The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma".Current Advances in Osteosarcoma. Advances in Experimental Medicine and Biology. Vol. 1257. pp. 75–83.doi:10.1007/978-3-030-43032-0_7.ISBN 978-3-030-43031-3.PMID 32483732.S2CID 219169967.
  3. ^Wang Y, Xie Q, Tan H, Liao M, Zhu S, Zheng LL, et al. (November 2021). "Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies".Pharmacological Research.173 105702.doi:10.1016/j.phrs.2021.105702.PMID 34102228.S2CID 235378858.
  4. ^Lian B, Chen X, Shen K (2023)."Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer".Frontiers in Immunology.14 1164514.doi:10.3389/fimmu.2023.1164514.PMC 10034161.PMID 36969235.
  5. ^US 2009/0263353, Maier T, Beckers T, Hummel RP, Feth M, Muller M, Bar T, Volz J, "Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles", issued 31 July 2012, assigned to 4SC AG 
  6. ^"Company Prepares for Pivotal Phase 3 Study of Entinostat, Most Advanced HDAC Inhibitor in Development for ER+ Metastatic Breast Cancer"(PDF).Syndax Pharmaceuticals. 27 August 2013. Archived fromthe original(PDF) on 17 June 2016.
  7. ^Hong SH, Castro G, Wang D, Nofsinger R, Kane M, Folias A, et al. (February 2024)."Targeting nuclear receptor corepressors for reversible male contraception".Proceedings of the National Academy of Sciences of the United States of America.121 (9) e2320129121.Bibcode:2024PNAS..12120129H.doi:10.1073/pnas.2320129121.PMC 10907271.PMID 38377195.
SPs/MIs
(M phase)
Blockmicrotubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDT
Other
Enzyme inhibitors
Receptor antagonists
Other/ungrouped


Stub icon

Thisantineoplastic orimmunomodulatorydrug article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Entinostat&oldid=1314089767"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp